stockrowAurora Cannabis Inc.
ACB Healthcare Drug Manufacturers Specialty & Generic
Aurora Cannabis Inc.’s revenue for fiscal 2026 (year ended March 2026) was $232.0 million, down 5.95% from fiscal 2025.
- Revenue
- −31.2%
- EPS
- +75.0%
- Free cash flow
- −293.6%
- Total debt
- −82.5%
Quarter to June 2026, against a year earlier
Follow ACB
Alert me
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
103.04 | 110.78 | 119.21 | 107.71 |
Receivables |
33.92 | 31.69 | 32.27 | 29.68 | |
Inventory |
161.12 | 165.38 | 126.72 | 135.46 | |
Other current assets |
1.28 | 1.24 | 1.44 | 2.27 | |
Total current assets |
307.67 | 319.80 | 287.68 | 284.19 | |
Property, Plant, Equpment (Net) |
190.33 | 185.86 | 89.53 | 106.00 | |
Long-Term Investments |
— | — | 8.77 | 9.05 | |
Long-term receivables |
3.25 | 2.92 | 2.65 | 2.34 | |
Goodwill and Intangible Assets (Total) |
43.97 | 43.97 | 42.05 | 43.39 | |
Long Term Assets (Tax, Deferred) |
0.09 | 0.11 | 1.78 | 1.85 | |
Long-term assets (Other) |
4.10 | 3.45 | 2.62 | 1.64 | |
Total non-current assets |
241.74 | 236.32 | 147.39 | 164.27 | |
Total Assets |
549.41 | 556.12 | 435.07 | 448.46 | |
Accounts Payable |
35.82 | 48.80 | 36.62 | 41.05 | |
Current Part of Debt |
43.38 | 44.31 | — | — | |
Current Part of Capital Lease |
4.06 | 4.32 | 4.15 | 4.24 | |
Current Part of Taxes to Pay |
4.50 | 4.61 | 5.04 | 5.37 | |
Current Revenue (Deferred) |
1.04 | 1.37 | 0.92 | 0.58 | |
Other current liabilities |
1.30 | 1.27 | 1.72 | 1.80 | |
Total current liabilities |
90.10 | 104.68 | 48.44 | 53.04 | |
Long Term Debt (Total) |
25.40 | 23.81 | 13.12 | 12.14 | |
Long Term Tax Liability (Deferred) |
2.53 | 2.50 | — | 0.03 | |
Non-current Liabilities (Other) |
19.73 | 17.83 | 3.04 | 2.50 | |
Total non-current liabilities |
47.65 | 44.14 | 16.16 | 14.68 | |
Total liabilities |
137.75 | 148.82 | 64.60 | 67.71 | |
Additional Paid In Capital |
115.24 | 113.86 | 115.89 | 114.71 | |
Common Stock (Net) |
5,077.74 | 5,019.02 | 5,071.83 | 5,076.31 | |
Retained Earnings |
(4,650.08) | (4,593.91) | (4,662.65) | (4,655.90) | |
Common Equity (Total) |
411.66 | 407.30 | 370.46 | 380.75 | |
Shareholders Equity (Total) |
411.66 | 407.30 | 370.46 | 380.75 | |
Shareholders Equity and Liabilities (Total) |
549.41 | 556.12 | 435.07 | 448.46 | |
Shares (Common) |
56.58 | 56.71 | 58.95 | 63.31 | |
Shareholders Equity (Tangible) |
367.68 | 363.33 | 328.42 | 337.36 | |
Net Debt |
(34.26) | (42.65) | (106.08) | (95.56) | |
Total Debt |
68.78 | 68.12 | 13.12 | 12.14 |